Market closedNon-fractional

DexCom/DXCM

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About DexCom

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

Ticker

DXCM

Sector

Healthcare

Trading on

NASDAQ

Industry

Health Care Equipment and Supplies

Headquarters

San Diego, United States

Employees

9,550

DexCom Metrics

BasicAdvanced
$44B
Market cap
72.65
P/E ratio
$1.54
EPS
1.21
Beta
-
Dividend rate
$44B
1.21
2.898
2.435
114.358
115.28
32.10%
6.79%
28.54%
72.653
11.362
19.67
21.04
74.027
25.78%
116.03%
23.33%
4.99%

What the Analysts think about DexCom

Analyst Ratings

Majority rating from 26 analysts.
Buy

DexCom Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
15.89% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$921M
-10.97%
Net income
$146M
-42.88%
Profit margin
15.89%
-35.85%

DexCom Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 18.50%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.34
$0.50
$0.50
$0.32
-
Expected
$0.23
$0.34
$0.43
$0.27
$0.39
Surprise
50.30%
46.74%
15.87%
18.50%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for DexCom stock?

DexCom (DXCM) has a market cap of $44B as of July 23, 2024.

What is the P/E ratio for DexCom stock?

The price to earnings (P/E) ratio for DexCom (DXCM) stock is 72.65 as of July 23, 2024.

Does DexCom stock pay dividends?

No, DexCom (DXCM) stock does not pay dividends to its shareholders as of July 23, 2024.

When is the next DexCom dividend payment date?

DexCom (DXCM) stock does not pay dividends to its shareholders.

What is the beta indicator for DexCom?

DexCom (DXCM) has a beta rating of 1.21. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell DexCom stock

Buy or sell DexCom stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing